Search Results 3551-3560 of 21156 for rash

  1. Amifampridine (oral route) - Mayo Clinic

    Tell your doctor right away if you have a rash, itching, hoarseness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after ...

  2. Science Saturday: The art and science of never giving up - Mayo Clinic News Network

    ... rash, shown at left above, along with other symptoms. Then in November, she had to be taken to the emergency department after weeks of reactions to ...

  3. Publications - Fiona E. Craig, M.D. - Mayo Clinic

    Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sezary syndrome.

  4. Niacin and lovastatin (oral route) - Side effects & dosage - Mayo Clinic

    rash; runny nose; shivering; shortness of breath; sore throat; sweating; trouble sleeping. Less common. Acid or sour stomach; belching; heartburn; indigestion ...

  5. Fibrinogen and thrombin, human (topical application route) - Side effects & uses - Mayo Clinic

    Tell your doctor right away if you have a rash, itching, hives, chest pain, dizziness or lightheadedness, trouble breathing, trouble swallowing, or any ...

  6. Fish oil - Mayo Clinic

    Rash. Taking high doses of fish oil supplements might increase the risk of bleeding and possibly increase the risk of stroke. Interactions. Possible ...

  7. Heparin and dextrose (intravenous route) - Side effects & uses - Mayo Clinic

    hives, itching, skin rash; inability to move the arms, legs, or facial muscles; inability to speak; increased menstrual flow or vaginal bleeding; large amount ...

  8. Technetium tc 99m sulfurcolloid (injection route, route not applicable) - Side effects & uses - Mayo Clinic

    hives or welts; itching; lightheadedness; puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue; rash; redness of the skin; shortness ...

  9. Pitolisant (oral route) - Side effects & dosage - Mayo Clinic

    fast or irregular heartbeat; fainting; hives, itching, skin rash; irritability; lack of appetite; loss of interest or pleasure; puffiness or swelling of the ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Rash must cover less than 10% of body surface area;; Disease is well controlled at baseline and only requiring low-potency topical steroids;; No acute ...